A few rural towns are bucking the trend and building new hospitals

Clear­side Bio­med­ical re­port­ed pos­i­tive re­sults from a Phase 2b tri­al of its ty­ro­sine ki­nase in­hibitor in pa­tients with wet age-re­lat­ed mac­u­lar de­gen­er­a­tion, bol­ster­ing its prospects

Following the news, which was announced on 19 September, ARS’s stock dropped by over 50% in pre-market trading. Image Credit: Alexandr Shatilov / Shutterstock. The

FDA Commissioner Robert Califf, MD, described his agency’s role in helping to prevent a wider outbreak of H5N1 avian influenza during a hearing of the